Evidence map›Paper›PMID 21204265›Full record

ArticleEMBO molecular medicine2011

Hsp72 is an early and sensitive biomarker to detect acute kidney injury.

Jonatan Barrera-Chimal, Rosalba Pérez-Villalva, Cesar Cortés-González, Marcos Ojeda-Cervantes, Gerardo Gamba, Luis E Morales-Buenrostro, Norma A Bobadilla

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02417896 naunknown statusnot on this mapstarted 2013, after this paper: background citation

Pilot Non Randomised Controlled Trial of Short Term Spironolactone Use for Prevention of Acute Kidney Injury After Cardiac Surgery

TypeinterventionalSponsorInstituto Nacional de Cardiologia Ignacio ChavezRan2013 to 2015Enrolled150ConditionsAcute Kidney Injuries, Kidney Injuries, Acute, Kidney Injury, Acute, Acute Renal InjuryArmsSpironolactone
NCT03206658 phase3unknown statusnot on this mapstarted 2017, after this paper: background citation

Usefulness of Spironolactone for the Prevention of Acute Kidney Injury in Critically Ill Patients With Invasive Mechanical Ventilation

TypeinterventionalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2017 to 2019Enrolled90ConditionsAcute Kidney InjuryArmsSpironolactone 25 mg, Placebo oral capsule
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Effect of sodium (PeerJ · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jonatan Barrera-ChimalMolecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Rosalba Pérez-Villalva
Cesar Cortés-González
Marcos Ojeda-Cervantes
Gerardo Gamba
Luis E Morales-Buenrostro
Norma A Bobadilla
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was designed to assess whether heat shock protein Hsp72 is an early and sensitive biomarker of acute kidney injury (AKI) as well as to monitor a renoprotective strategy. Seventy-two Wistar rats were divided into six groups: sham-operated and rats subjected to 10, 20, 30, 45 and 60 min of bilateral ischemia (I) and 24 h of reperfusion (R). Different times of reperfusion (3, 6, 9, 12, 18, 24, 48, 72, 96 and 120 h) were also evaluated in 30 other rats subjected to 30 min of ischemia. Hsp72 messenger RNA (mRNA) and protein levels were determined in both kidney and urine. Hsp72-specificity as a biomarker to assess the success of a renoprotective intervention was evaluated in rats treated with different doses of spironolactone before I/R. Renal Hsp72 mRNA and protein, as well as urinary Hsp72 levels, gradually increased relative to the extent of renal injury induced by different periods of ischemia quantified by histomorphometry as a benchmark of kidney damage. Urinary Hsp72 increased significantly after 3 h and continued rising until 18 h, followed by restoration after 120 h of reperfusion in accord with histopathological findings. Spironolactone renoprotection was associated with normalization of urinary Hsp72 levels. Accordingly, urinary Hsp72 was significantly increased in patients with clinical AKI before serum creatinine elevation. Our results show that urinary Hsp72 is a useful biomarker for early detection and stratification of AKI. In addition, urinary Hsp72 levels are sensitive enough to monitor therapeutic interventions and the degree of tubular recovery following an I/R insult.

Indexed as

Acute Kidney InjuryAcute-Phase ProteinsAnimalsBiomarkersCreatineHepatitis A Virus Cellular Receptor 1HSP72 Heat-Shock ProteinsHumansInterleukin-18IschemiaLipocalin-2LipocalinsMembrane GlycoproteinsProto-Oncogene ProteinsRatsRats, WistarAcute-Phase ProteinsBiomarkersCreatineHAVCR1 protein, humanHepatitis A Virus Cellular Receptor 1HSP72 Heat-Shock ProteinsInterleukin-18LCN2 protein, humanLipocalin-2LipocalinsMembrane GlycoproteinsProto-Oncogene ProteinsReceptors, VirusSpironolactone

Identifiers

PMID21204265
PMCPMC3401998
OpenAlexW2130211650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.